Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy

Abstract Background The aim of this review is to provide an overview on diverse anticancer activities of 2-substituted benzimidazole derivatives. Main body This review provides a correlation between the various mechanisms of action of benzimidazoles as anticancer and the substitution pattern around...

Full description

Bibliographic Details
Main Authors: Heba A. Ibrahim, Hanan M. Refaat
Format: Article
Language:English
Published: SpringerOpen 2020-07-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://link.springer.com/article/10.1186/s43094-020-00048-8
_version_ 1818082186417405952
author Heba A. Ibrahim
Hanan M. Refaat
author_facet Heba A. Ibrahim
Hanan M. Refaat
author_sort Heba A. Ibrahim
collection DOAJ
description Abstract Background The aim of this review is to provide an overview on diverse anticancer activities of 2-substituted benzimidazole derivatives. Main body This review provides a correlation between the various mechanisms of action of benzimidazoles as anticancer and the substitution pattern around the nucleus. Conclusion The linker group and substitution at N-1, C-2, C-5, and C-6 positions have been found to be the most contributory factors for anticancer activity. This will help in the further design to afford more selective, potent, and multi-target anticancer of 2-substituted benzimidazole-based compounds.
first_indexed 2024-12-10T19:18:06Z
format Article
id doaj.art-495eef56639644cc923e7e17352e20ce
institution Directory Open Access Journal
issn 2314-7253
language English
last_indexed 2024-12-10T19:18:06Z
publishDate 2020-07-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-495eef56639644cc923e7e17352e20ce2022-12-22T01:36:32ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532020-07-016112010.1186/s43094-020-00048-8Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapyHeba A. Ibrahim0Hanan M. Refaat1Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in EgyptDepartment of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in EgyptAbstract Background The aim of this review is to provide an overview on diverse anticancer activities of 2-substituted benzimidazole derivatives. Main body This review provides a correlation between the various mechanisms of action of benzimidazoles as anticancer and the substitution pattern around the nucleus. Conclusion The linker group and substitution at N-1, C-2, C-5, and C-6 positions have been found to be the most contributory factors for anticancer activity. This will help in the further design to afford more selective, potent, and multi-target anticancer of 2-substituted benzimidazole-based compounds.http://link.springer.com/article/10.1186/s43094-020-00048-8HeterocyclicBenizimidazoleAnticancerCytotoxic effect
spellingShingle Heba A. Ibrahim
Hanan M. Refaat
Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
Future Journal of Pharmaceutical Sciences
Heterocyclic
Benizimidazole
Anticancer
Cytotoxic effect
title Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
title_full Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
title_fullStr Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
title_full_unstemmed Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
title_short Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy
title_sort versatile mechanisms of 2 substituted benzimidazoles in targeted cancer therapy
topic Heterocyclic
Benizimidazole
Anticancer
Cytotoxic effect
url http://link.springer.com/article/10.1186/s43094-020-00048-8
work_keys_str_mv AT hebaaibrahim versatilemechanismsof2substitutedbenzimidazolesintargetedcancertherapy
AT hananmrefaat versatilemechanismsof2substitutedbenzimidazolesintargetedcancertherapy